ASCLETIS PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.34 HKD | -1.47% |
|
+4.69% | -8.22% |
| 04-03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
| 04-03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |
Chart calendar Ascletis Pharma Inc.
9fb.4jC9hFNEeZMcq15_hMd7roh9dI3TyPQ87FV_M-mrUiY.rHeJ3mQ1HtlUkg4swfEL4d9LA8a6sbZliSRPBKzjJxS6BfXtEiEo-Sr4Dw~da0b9091cb15231df42e1f4171a58d3c
Upcoming events on Ascletis Pharma Inc.
Past events on Ascletis Pharma Inc.
| 2024-03-24 | Q4 2023 Earnings Release |
| 2024-03-09 | American Academy of Dermatology Meeting |
| 2023-11-11 | American Association for the Study of Liver Diseases Conference - Poster ID: 2401-C |
| 2023-11-11 | American Association for the Study of Liver Diseases Conference - Poster ID: 5052-C |
| 2023-11-07 | International Workshop on HBV Cure |
| 2023-10-09 | European Academy of Dermatology and Venereology Congress - Poster #P0053 |
| 2023-08-20 | Q2 2023 Earnings Release |
| 2023-07-22 | International AIDS Society Conference |
| 2023-03-19 | Q4 2022 Earnings Release |
| 2023-02-19 | Retroviruses and Opportunistic Infections Conference |
| 2023-02-15 | Asian Pacific Association for the Study of the Liver Meeting |
| 2022-11-05 | American Association for the Study of Liver Diseases Meeting - Abstract 2314 |
| 2022-08-21 | Interim 2022 Earnings Release |
| 2022-06-25 03:15 | European Association for the Study of the Liver International Liver Congress - Abstract Number: OS09 |
| 2022-06-25 02:15 | International Liver Congress - Abstract No: OS091 |
| 2022-04-08 13:00 | American Association of Cancer Research Meeting - Abstract #5529 |
| 2022-04-08 13:00 | American Association of Cancer Research Meeting - Abstract #5466 |
| 2022-03-20 | FY 2021 Earnings Release |
| 2021-11-15 12:30 | American Association for the Study of Liver Diseases Meeting - #LO12 |
| 2021-11-14 10:00 | AASLD The Liver Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 166 166 -0.04% | 173 166 4.34% | 35,0 198 -82.31% | 76,9 68,0 13.03% | 54,1 157 -65.59% | 56,6 54,6 3.71% |
|
EBITDA Million CNY | Released Forecast Spread | -133 -97,5 -36.14% | -189 -251 24.72% | -258 -32,0 -706.18% | -217 -173 -25.46% | -374 -169 -120.63% | -290 -199 -45.78% |
|
EBIT Million CNY | Released Forecast Spread | -145 -100 -44.37% | -211 -206 -2.29% | -285 -44,9 -534.71% | -247 -187 -32.2% | -404 -190 -113.04% | -309 -221 -39.95% |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -19,9 -14,0 -41.93% | -96,0 -127 24.52% | -209 -29,2 -616.63% | -199 -167 -18.95% | -315 -148 -112.57% | -145 -92,3 -56.75% |
|
Net income Million CNY | Released Forecast Spread | -7,26 -2,00 -262.9% | -96,0 -127 24.52% | -209 -29,2 -616.63% | -199 -167 -18.95% | -315 -148 -112.57% | -145 -130 -11.62% |
|
EPS CNY | Released Forecast Spread | 0,00 0,00 - | -0,09 -0,12 20.87% | -0,20 -0,03 -570.67% | -0,18 -0,16 -13.31% | -0,29 -0,14 -113.73% | -0,13 -0,12 -12.88% |
| Announcement Date | 24/03/19 | 24/03/20 | 30/03/21 | 21/03/22 | 19/03/23 | 25/03/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 75,4 145 -48.1% | 98,0 93,5 4.89% | 31,8 81,0 -60.69% | 3,17 128 -97.52% | 36,5 26,3 39.02% | 40,3 33,5 20.35% | 38,2 50,8 -24.74% | 15,9 42,4 -62.57% | 46,5 46,5 0.01% | 10,1 20,7 -51.26% | 0,00 | 0,00 |
|
EBIT Million CNY | Released Forecast Spread | -80,3 -73,8 -8.78% | -229 -148 -54.24% | -177 | -194 | ||||||||
|
EPS CNY | Released Forecast Spread | -0,05 -0,05 7.4% | -0,05 -0,01 -394% | -0,15 -0,01 -1418% | -0,10 -0,07 -44.14% | -0,08 -0,09 10.67% | -0,08 -0,07 -15.71% | -0,21 -0,15 -39.07% | -0,02 -0,02 24% | -0,12 -0,07 -70.71% | -0,12 | -0,14 | |
| Announcement Date | 29/08/19 | 24/03/20 | 28/08/20 | 30/03/21 | 26/08/21 | 21/03/22 | 22/08/22 | 19/03/23 | 22/08/23 | 25/03/24 | - | - |
More events
Past sector events for Ascletis Pharma Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1672 Stock
- Calendar Ascletis Pharma Inc.
